Yakira Capital Management’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-174,099
Closed -$4.88M 550
2022
Q1
$4.88M Buy
174,099
+106,967
+159% +$2.93M 0.7% 37
2021
Q4
$1.83M Buy
+67,132
New +$1.82M 0.23% 129

Yakira Capital Management's XENT Position: Q2 2022 in Review

Yakira Capital Management sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 174,099 shares — an estimated $4.88M sold.

Yakira Capital Management first reported a position in XENT in Q4 2021 and held it in 2 quarters. The position peaked at $4.88M in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

  • Yakira Capital Management reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
  • Yakira Capital Management sold 174,099 Intersect ENT, Inc shares in Q2 2022, an estimated $4.88M.
  • Yakira Capital Management first reported a position in Intersect ENT, Inc in Q4 2021 and held it in 2 quarters.
  • Yakira Capital Management's Intersect ENT, Inc position peaked at $4.88M in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Yakira Capital Management's 13F filing for Q2 2022, filed 11 Aug 2022.